Rybelsus Lawsuit
Took Rybelsus (oral semaglutide) and suffered gastroparesis, intestinal blockage, or vision loss? Free case review.
Top Tier Legal LLC is not a law firm and does not provide legal advice. Submitting does not create an attorney-client relationship. If we share your information with a law firm, it is for evaluation only; the firm will independently decide whether to contact you. Outcomes are not guaranteed.
Top Tier Legal LLC is not a law firm and does not provide legal advice. Submitting does not create an attorney-client relationship. If we share your information with a law firm, it is for evaluation only; the firm will independently decide whether to contact you. Outcomes are not guaranteed.
You may qualify if:
- Used Rybelsus (oral semaglutide)
- Treated for a serious injury after use
Statutes of limitations vary by state and injury type. Contact us promptly to protect your rights.
Rybelsus Lawsuits
Rybelsus is an oral semaglutide medication manufactured by Novo Nordisk. Like injectable GLP-1 drugs, it is named in MDL 3094. Plaintiffs allege Novo Nordisk failed to adequately warn about gastrointestinal and vision-related risks.
Related practice area
GLP-1 vision loss claimsDo not stop taking a prescribed medication without first consulting your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. This page is for informational purposes only and does not constitute legal or medical advice.
Common Symptoms & Health Effects
Frequently Asked Questions
These answers explain eligibility, timelines, and how review works for this claim type.
Expand a question for detail before you start a free, confidential case review.
See If You Qualify
Start a free, confidential case review to see whether you may qualify before filing deadlines pass.
Statutes of limitations vary by state and claim type.